Patent Assignment
Reel/Frame 036126/0377
Merger
Recorded: 2015-07-16
Pages: 8
Assignor
OXFORD AMHERST CORPORATION
Executed: 2015-05-26
Assignee
PHARMACYCLICS, INC.
995 EAST ARQUES AVENUE, SUNNYVALE, CALIFORNIA, 94085
Covered Properties
(81)
Methods for Cancer Chemosensitization
Patent:
5,776,925 →
Application:
08/591,318 →
Method and Compositions for Treating Atheroma, Tumors and Other Neoplastic Tissue
Patent:
6,825,186 →
Application:
09/699,027 →
Protease Inhibitors
Patent:
6,867,200 →
Application:
09/868,276 →
Novel Metallotexaphyrin Derivatives
Histone Deacetylase-8 Proteins, Nuclei Acids, and Methods for Use
Patent:
6,875,598 →
Application:
10/239,333 →
Metal Free Texaphyrin Synthesis
Patent:
6,657,058 →
Application:
10/274,776 →
Non-Symmetric Tripyrranes in the Synthesis of Novel Macrocycles
2-(2-Hydroxybiphenyl-3-Yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor Viia Inhibitors
Novel Metallotexaphyrin Derivatives
Novel Hydroxamates as Therapeutic Agents
Acetylene Derivatives as Inhibitors of Histone Deacetylase
Histone Deacetylase-8 Proteins, Nucleic Acids, and Methods for Use
Methods and Compositions for Treating Atheroma, Tumors and Other Neoplastic Tissue
Texaphyrin Coordination Compounds and Uses Thereof
Novel Hydroxamates as Therapeutic Agents
Methods and Compositions for Treating Atheroma, Tumors and Other Neoplastic Tissues
Methods and Compositions for Treating Atheroma, Tumors and Other Neoplastic Tissues
Inhibitors of Bruton's Tyrosine Kinase
Indole Derivatives as Inhibitors of Histone Deacetylase
Inhibitors of Bruton's Tyrosine Kinase
Intracellular Kinase Inhibitors
Uses of Selective Inhibitors of HDAC8 for Treatment of T-Cell Proliferative Disorders
Novel Hydroxamates as Therapeutic Agents
Bruton's Tyrosine Kinase Activity Probe and Method of Using
Novel Hydroxamates as Therapeutic Agents
Novel Hydroxamates as Therapeutic Agents
Inhibitors of Bruton's Tyrosine Kinase
Methods for Determining Cancer Resistance to Histone Deacetylase Inhibitors
Inhibitors of Brutons Tyrosine Kinase
Novel Hydroxamates as Therapeutic Agents
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Tyrosine Kinases and Uses Thereof
Pyrazolo-Pyrimidine Inhibitors of Bruton's Tyrosine Kinase
Patent:
7,718,662 →
Application:
12/581,044 →
Pyrazolo-Pyrimidine Inhibitors of Bruton's Tyrosine Kinase
Patent:
7,741,330 →
Application:
12/581,062 →
Inhibitors of Bruton's Tyrosine Kinase
High-Purity Texaphyrin Metal Complexes
Manufacture, Compositions and Uses of Coagulation Factor Viia Modulator
Formulations of Histone Deacetylase Inhibitor and Uses Thereof
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Novel Hydroxamates as Therapeutic Agents
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Selective Inhibitors of Histone Deacetylase
Inhibitors of Bruton's Tyrosine Kinase
Factor Viia Inhibitor
2-(2-Hydroxybiphenyl-3-Yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor Viia Inhibitors
Inhibitors of Bruton's Tyrosine Kinase
Novel Hydroxamates as Therapeutic Agents
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Purinone Compounds as Kinase Inhibitors
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Pyrazolo[3,4-D]Pyrimidine and Pyrrolo[2,3-D]Pyrimidine Compounds as Kinase Inhibitors
Patent:
8,377,946 →
Application:
13/529,911 →
Inhibitors of Bruton's Tyrosine Kinase
Inhibitors of Bruton's Tyrosine Kinase
Administration Regime for N-Hydroxy-4-{2-[3-(N,N-Dimethylaminomethyl)Benzofuran-2-Ylcarbonylamino]Ethoxy}Benzamide
Inhibitors of Bruton's Tyrosine Kinase
2-(2-Hydroxybiphenyl-3-Yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor Viia Inhibitors
Factor Viia Inhibitor
Inhibitors of Bruton's Tyrosine Kinase
MANUFACTURE, COMPOSITIONS AND USES OF COAGULATION FACTOR VIIa MODULATOR
Indole Derivatives as Inhibitors of Histone Deacetylase
Novel Hydroxamates as Therapeutic Agents
Inhibitors of Bruton's Tyrosine Kinase
Selective Inhibitors of Histone Deacetylase
Inhibitors of Bruton's Tyrosine Kinase
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 4, 2002
From: ALLEN, DARIN A.; HATAYE, JASON M.; HRUZEWICZ, WITOLD; KOLESNIKOV, ALEKSANDR
To: AXYS PHARMACEUTICALS, INC.
Reel/Frame 012430/0396 →
Assignment of Assignor's Interest
Jan 17, 2002
From: MODY, TARAK D.; GALANTER, JOSHUA
To: PHARMACYCLICS, INC.
Reel/Frame 012476/0616 →
Assignment of Assignor's Interest
Feb 26, 2003
From: MODY, TARAK D.; GALANTER, JOSHUA
To: PHARMACYCLICS, INC.
Reel/Frame 014152/0906 →
Assignment of Assignor's Interest
May 6, 2004
From: MODY, TARAK; GALANTER, JOSHUA
To: PHARMACYCLICS, INC.
Reel/Frame 015298/0575 →
Assignment of Assignor's Interest
Mar 29, 2005
From: SENDZIK, MARTIN
To: AXYS PHARMACEUTICALS, INC
Reel/Frame 015968/0094 →
Assignment of Assignor's Interest
May 3, 2005
From: VERNER, ERIK J.; SENDZIK, MARTIN; BASKARAN, CHITRA; BUGGY, JOSEPH J.
To: AXYS PHARMACEUTICALS, INC.
Reel/Frame 016188/0375 →
Assignment of Assignor's Interest
Sep 22, 2005
From: VERNER, ERIK J.; SENDZIK, MARTIN; BASKARAN, CHITRA; BUGGY, JOSEPH J.
To: AXYS PHARMACEUTICALS, INC.
Reel/Frame 016839/0412 →
Assignment of Assignor's Interest
Oct 21, 2005
From: KOLESNIKOV, ALEKSANDR; RAI, ROOPA; SHRADER, WILLIAM DVORAK; TORKELSON, STEVEN M.
To: AXYS PHARMACEUTICALS, INC.
Reel/Frame 016923/0724 →
Assignment of Assignor's Interest
Dec 5, 2005
From: VERNER, ERIK J.; SENDZIK, MARTIN; BASKARAN, CHITRA; BUGGY, JOSEPH J.
To: AXYS PHARMACEUTICALS INC
Reel/Frame 017090/0464 →
Assignment of Assignor's Interest
Jun 29, 2006
From: AXYS PHARMACEUTICALS, INC.
To: PHARMACYCLICS, INC.
Reel/Frame 017855/0717 →
Assignment of Assignor's Interest
Aug 31, 2006
From: MADGA, DARREN
To: PHARMACYCLICS, INC.
Reel/Frame 018225/0127 →
Assignment of Assignor's Interest
Aug 31, 2006
From: SESSLER, JONATHAN L.
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, THE
Reel/Frame 018225/0838 →
Assignment of Assignor's Interest
Oct 11, 2006
From: AXYS PHARMACEUTICALS, INC.
To: PHARMACYCLICS, INC.
Reel/Frame 018378/0718 →
Assignment of Assignor's Interest
Jun 20, 2007
From: AXYS PHARMACEUTICALS, INC.
To: PHARMACYCLICS, INC.
Reel/Frame 019455/0206 →
Assignment of Assignor's Interest
Jul 10, 2007
From: SETTI, EDUARDO L.
To: AXYS PHARMACEUTICALS, INC.
Reel/Frame 019537/0165 →
Assignment of Assignor's Interest
Jul 10, 2007
From: BUGGY, JOSEPH J.; BALASUBRAMANIAN, SRIRAM; VERNER, ERIK; TAI, VINCENT W.F.
To: PHARMACYLICS, INC.
Reel/Frame 019539/0151 →
Assignment of Assignor's Interest
Jul 10, 2007
From: AXYS PHARMACEUTICALS, INC.
To: PHARMACYCLICS, INC.
Reel/Frame 019539/0250 →
Assignment of Assignor's Interest
Jul 24, 2007
From: HONIGBERG, LEE; VERNER, ERIK; ZHENGYING, PAN
To: PHARMACYCLICS, INC.
Reel/Frame 019602/0702 →
Security Agreement
Aug 3, 2007
From: VITA SPECIAL PURPOSE CORP.
To: LB I GROUP INC.
Reel/Frame 019649/0291 →
Assignment of Assignor's Interest
Sep 12, 2008
From: APPLERA CORPORATION
To: CELERA CORPORATION
Reel/Frame 021561/0124 →
Assignment of Assignor's Interest
Apr 13, 2009
From: AXYS PHARMACEUTICALS, INC.
To: PHARMACYCLICS, INC.
Reel/Frame 022529/0676 →
Release of Lien in Intellectual Property
Jul 26, 2011
From: LB I GROUP INC.
To: ORTHOVITA, INC. (FOR ITSELF AND AS SUCCESSOR BY MERGER TO VITA LICENSING, INC. AND PARTISYN CORP.); ORTHOVITA INTERNATIONAL SERVICES, INC.; VITA SPECIAL PURPOSE CORP.
Reel/Frame 026648/0422 →
Assignment of Assignor's Interest
Feb 20, 2015
From: BUGGY, JOSEPH
To: AXYS PHARMACEUTICALS, INC.
Reel/Frame 034997/0738 →
Merger and Change of Name
Jul 16, 2015
From: PHARMACYCLICS, INC.; OXFORD AMHERST LLC
To: PHARMACYCLICS LLC
Reel/Frame 036126/0398 →
Corrective Assignment to Correct the Conveying Party Data Previously Recorded on Reel 036126 Frame 0377. Assignor(S) Hereby Confirms the Merger.
May 17, 2016
From: OXFORD AMHERST CORPORATION; PHARMACYCLICS, INC.
To: PHARMACYCLICS, INC.
Reel/Frame 038722/0776 →